On August 5, Hinge Health, Inc. fell 5.5% in after-hours trading, trading at $76.26/share, with turnover of $15.347 million. The decline followed the company's Q2 earnings release after market close.

Hinge Health reported Q2 adjusted earnings of $0.59 per share, which met the analyst consensus estimate but represented a 13.24% decrease from $0.68 per share in the same period last year. Revenue came in at $212.8 million, beating the consensus estimate of $201.0 million. Despite the top-line beat, the market appeared disappointed by the lack of EPS upside and the year-over-year earnings deterioration.

Notably, the stock had risen approximately 5% during regular trading ahead of the earnings release, suggesting expectations had been priced in. Hinge Health is an AI-driven digital musculoskeletal care platform that provides end-to-end services from acute injury management to post-surgical recovery through wearable devices and clinical teams. Multiple analysts maintain buy ratings on the stock, with Morgan Stanley recently raising its price target to $108.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)